Try it
Biochemistry · Nucleotide metabolism: trimethoprim selectivity
Sample itemTrimethoprim blocks nucleotide synthesis in bacteria but is relatively safe for human cells. Which property accounts for this selectivity?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. It binds bacterial dihydrofolate reductase far more tightly than the human enzyme
Trimethoprim is a folate analogue with far higher affinity for bacterial dihydrofolate reductase than for the human enzyme. Blocking the bacterial enzyme depletes tetrahydrofolate and so thymidylate and purines.
Option by option
A. It binds bacterial dihydrofolate reductase far more tightly than the human enzyme (correct)
Correct. Its affinity for the bacterial reductase is far higher than for the human one.
B. It cannot enter human cells, which lack folate carriers
Human cells have folate carriers, and entry of the drug is not the basis of selectivity.
C. It is activated only by bacterial thymidine kinase
Trimethoprim does not need activation by a thymidine kinase.
D. It inhibits dihydropteroate synthase, found only in bacteria
Dihydropteroate synthase is the target of sulfonamides, not trimethoprim.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Biochemistry questions
- Nucleotide metabolismA 4-year-old boy has intellectual disability, dystonia, self-mutilation and hyperuricaem…
- VitaminsA patient with megaloblastic anaemia and mild neurological signs has raised serum methyl…
- Amino acid metabolismA baby has a mousy odour, fair skin and developmental delay. Which enzyme is deficient?
- Glycogen storage diseasesA child has severe fasting hypoglycaemia, hepatomegaly, lactic acidosis and hyperuricaem…